Doctor profile · Federal record
Dr. Lindsey Broussard
Dermatology Physician (CMS: Dermatology) · Denver, CO
- NPI 1679006597
- Accepts Medicare
- MIPS 83.1 / 100 · 2023
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3540 S Poplar St Ste 300
Denver, CO 802371364
(303) 850-9715
Credentials & registration
- NPI registered
- April 2017 — 9 yrs on file
- Profile last updated
- October 10, 2023
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Colorado #DR.0070927
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1679006597. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
428
Distinct HCPCS
6
Medicare allowed
$20,180
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 217 | 39 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 78 | 75 | $91 | |
17000 |
Destruction of precancer skin growth, 1 growth | 54 | 53 | $51 | |
11102 |
Biopsy of related skin growth, first growth | 31 | 31 | $93 | |
17110 |
Destruction of skin growth, 1-14 growths | 24 | 23 | $118 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 24 | 23 | $129 |
In context: peer comparison
Among 17 peers in this city , average services per provider: 128. This provider delivers 3.3× the peer median.Open Payments
Industry payments received
All-time total
$3,436
Transactions
137
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 27 | $669.97 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $399.13 | |
| GENZYME CORPORATION | 14 | $341.22 | |
| Regeneron Healthcare Solutions, Inc. | 10 | $292.58 | |
| Novartis Pharmaceuticals Corporation | 13 | $226.27 | |
| PFIZER INC. | 9 | $225.62 | |
| UCB, Inc. | 11 | $220.57 | |
| Dermavant Sciences, Inc. | 11 | $211.34 | |
| Amgen Inc. | 6 | $181.47 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $170.92 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $99.00 | |
| Janssen Biotech, Inc. | 4 | $87.63 | |
| Arcutis Biotherapeutics, Inc. | 4 | $82.64 | |
| Galderma Laboratories, L.P. | 3 | $69.93 | |
| LEO Pharma Inc. | 3 | $68.63 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
23
Patients
11
Total drug cost
$456
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 12 | 0 | $295 |
| Triamcinolone Acetonide | Generic | 11 | 11 | $160 |
Frequently asked questions
What is Dr. Lindsey Broussard's medical specialty?
Dr. Lindsey Broussard practices Dermatology Physician in Denver, CO.
Where does Dr. Lindsey Broussard practice?
Dr. Lindsey Broussard practices at 3540 S Poplar St Ste 300, Denver, CO 802371364. Office phone: 3038509715.
What is Dr. Lindsey Broussard's NPI?
Dr. Lindsey Broussard's National Provider Identifier (NPI) is 1679006597, issued by NPPES.
Does Dr. Lindsey Broussard accept Medicare assignment?
Yes. Dr. Lindsey Broussard accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lindsey Broussard commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.